back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-11 18:18 Tx date 2023-12-11 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
97 - Other
|
-1,000,000 vol |
3,845,072 | |
| Filed 2023-11-29 12:07 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325,000 vol $899.50 each |
$325,000 | |
| Filed 2023-11-29 11:45 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+4,845,072 vol |
4,845,072 | |
| Filed 2023-11-29 11:44 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325,000 vol $899.50 each |
||
| Filed 2023-11-29 11:44 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325,000 vol $899.50 each |
$325,000 | |
| Filed 2023-11-23 14:20 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325 vol $899.50 each |
||
| Filed 2023-11-23 14:20 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325 vol $899.50 each |
||
| Filed 2023-05-24 12:18 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+5,062,016 vol |
||
| Filed 2023-11-23 14:20 Tx date 2023-11-20 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
$
+$325 vol $899.50 each |
$325 | |
| Filed 2023-11-23 14:18 Tx date 2023-10-01 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-03 15:35 Tx date 2023-10-30 |
$TRYP
Tryp Therapeutics Inc. |
Gilligan, James Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$216,000
+2,000,000 vol $0.108 each |
5,769,684 | |
| Filed 2023-11-03 15:34 Tx date 2023-10-30 |
$TRYP
Tryp Therapeutics Inc. |
Molloy, Peter Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$81,000
+750,000 vol $0.108 each |
2,350,000 | |
| Filed 2023-10-31 13:50 Tx date 2023-10-30 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$833,063
+7,713,548 vol $0.108 each |
7,713,548 | |
| Filed 2023-10-31 13:49 Tx date 2023-10-01 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-11 18:36 Tx date 2023-10-11 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$175,000 vol $1,000 each |
$175,000 | |
| Filed 2023-10-11 18:24 Tx date 2023-10-01 |
$TRYP
Tryp Therapeutics Inc. |
Carroll, Jason Alan
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 12:24 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1,200,000 vol $1,000 each |
$1,200,000 | |
| Filed 2023-05-24 12:18 Tx date 2023-05-24 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+5,062,016 vol |
5,062,016 | |
| Filed 2023-05-24 12:14 Tx date 2022-05-16 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 12:11 Tx date 2023-04-26 |
$TRYP
Tryp Therapeutics Inc. |
Ntoumenopoulos, Christopher
4 - Director of Issuer
Holder: Sobol Capital PTY Ltd. (Indirect Ownership)
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100,000 vol $1,000 each |
$100,000 |